Natalia Gandarillas, MPharm
Associate Director, Medical Affairs / Medical Information – Strategic Initiatives & Business Growth
Expertise:
Natalia Gandarillas is the Associate Director of Medical Affairs / Medical Information at EVERSANA, where she leads strategic initiatives to strengthen global medical affairs operations and drive business growth. A pharmacist by training, Natalia brings more than 10 years of experience in pharma, biotech, and CROs, including roles at AstraZeneca, BioNTech, BioMarin, and Eli Lilly.
Natalia has built global medical information teams and served as product lead across multiple therapeutic areas, including oncology, rare diseases, diabetes, cardiovascular and infectious diseases, and vaccine technologies. Fluent in four languages, Natalia offers expertise in regulatory compliance, medical review, vendor management, and the application of emerging technologies—such as AI and NLP—to optimize medical communications and stakeholder engagement.
Natalia holds a Master of Pharmacy from San Pablo CEU University, an MSc in Management and Business Administration from Universidad Autónoma de Madrid, and a postgraduate certificate in Medical Devices from Universidade de Lisboa. Natalia is currently pursuing advanced studies in Artificial Intelligence in Healthcare at Imperial College London.
Articles by Natalia Gandarillas, MPharm
Content Evolution: Shifting to Component-Based Authoring and Modular Strategies
The pharmaceutical industry is experiencing a major transformation in how Medical Affairs teams create and share content with healthcare professionals and patients. Gone are the days of static, one-size-fits-all materials. Today, organizations are embracing component-based authoring and modular strategies—think reusable blocks like medical statements, graphs, and visuals that can be quickly assembled and tailored for […]
Interpretation of the Europe Regulatory Framework and Best Practices for MI Across the Pharma Industry
Navigating the European regulatory landscape for Medical Information (MI) is no easy feat. Recent research reveals that MI teams across pharma companies—large and small—face a patchwork of requirements and best practices, from consent handling and call recording to language support and patient access. Most organizations rely on contact center service providers and strive to cover […]